ReviewBrain tumor pathology2024

Oligodendroglioma, IDH-mutant and 1p/19q-codeleted-prognostic factors, standard of care and chemotherapy, and future perspectives with neoadjuvant strategy.

Hikaru Sasaki et al.PubMed ↗Publisher ↗

No numbers read from the abstract.